https://www.mskcc.org/cancer-care/clinical-trials/20-348
Full Title A Randomized Phase II Study of Systemic Chemotherapy with or without HAI FUDR/Dexamethasone in Patients with Unresectable Intrahepatic...
phase ii studygemcitabineoxaliplatinchemotherapy
https://www.patlynk.com/trial/NCT00085436
OBJECTIVES: Primary * Determine the clinical response rate in patients with metastatic renal cell carcinoma treated with autologous dendritic cells (DC) loade
phase ii studyautologoustumordcvaccine
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00542/full
Background: Proton beam has an excellent depth dose distribution due to its unique physical properties and thus proton beam therapy (PBT) has been tried and ...
phase ii studyproton beam therapyfrontiers
https://pubmed.ncbi.nlm.nih.gov/24677033/
This placebo-controlled phase II study evaluated the pharmacodynamics, efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), a fetal globin gene-inducing...
phase ii studydouble blindplacebo controlled
https://www.mobapcancerresearch.org/253-2/
Despite optimal therapy with radiation and concurrent and ad-juvant temozolomide (TMZ),1 survival is poor for most patients with glioblastoma (GBM), and...
phase iirandomizedadjuvantfactorialstudy
https://www.businesswire.com/news/home/20210305005205/en/Can-Fite-Enrolls-First-Patient-in-Phase-II-COVID-19-Study-Under-FDA-Protocol
Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
in phasefitefirstpatientii
https://pubmed.ncbi.nlm.nih.gov/9427794/
Previous report suggested that weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and leucovorin is a highly active and relatively low toxic regimen...
phase ii studyweeklyhourinfusion
https://pubmed.ncbi.nlm.nih.gov/36469573/
These data indicate that neoadjuvant durvalumab plus tremelimumab orchestrates de novo systemic immune responses that extend to the tumor microenvironment and...
window of opportunityphase iistudyneoadjuvantpd